Journal List > J Nutr Health > v.48(1) > 1081430

Lee, Kang, Kim, Kim, and Choe: A study of the lipoprotein lipase inhibitory mechanism of Poncirus trifoliata water extracts∗

Abstract

Purpose:

Poncirus trifoliata has been reported to have anti-inflammatory, antioxidant, and immune activities. However, its anti-obesity activity and the mechanism by which the water extract of dried, immature fruit of Poncirus trifoliata (PF-W) acts are not clear. This study suggests a potential mechanism associated with the anti-obesity activity of PF-W.

Methods:

We measured the effect of PF-W on lipoprotein lipase (LPL) regulation using enzyme-linked immunosorbent assay (ELISA) and an activity assay. The LPL regulation mechanism was examined by reverse transcription polymerase chain reaction (RT-PCR) to measure the mRNA expression of biomarkers related to protein transport and by western blot for analysis of the protein expression of the transcription factor CCAAT-enhancer-binding protein (C/EBPβ).

Results:

The total polyphenol and flavonoid content of PF-W was 52.15 ± 4.02 and 6.56 ± 0.47 mg/g, respectively. PF-W treatment decreased LPL content in media to 58 ± 5% of that in control adipocyte media, and increased LPL content to 117 ± 3.5% of that in control adipocytes, but did not affect the mRNA expression of LPL. PF-W also increased the mRNA expression of sortilin-related receptor (SorLA), a receptor that induces endocytosis and intracellular trafficking of LPL, in a concentration and time-dependent manner. Finally, cell fractionation revealed that PF-W treatment induced the expression of C/EBPβ, a SorLA transcription factor, in the nuclei of 3T3-L1 adipocytes.

Conclusion:

The LPL secretion and activity assay showed PF-W to be an LPL secretion inhibitor, and these results suggest the potential mechanism of PF-W involving inhibition of LPL secretion through C/EBPβ-mediated induction of SorLA expression.

REFERENCES

1.Spiegelman BM., Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell. 1996. 87(3):377–389.
crossref
2.Kopelman PG. Obesity as a medical problem. Nature. 2000. 404(6778):635–643.
crossref
3.Visscher TL., Seidell JC. The public health impact of obesity. Annu Rev Public Health. 2001. 22:355–375.
crossref
4.Chaput JP., St-Pierre S., Tremblay A. Currently available drugs for the treatment of obesity: Sibutramine and orlistat. Mini Rev Med Chem. 2007. 7(1):3–10.
crossref
5.Collins P., Williams G. Drug treatment of obesity: from past failures to future successes? Br J Clin Pharmacol. 2001. 51(1):13–25.
crossref
6.Li M., Cheung BM. Pharmacotherapy for obesity. Br J Clin Pharmacol. 2009. 68(6):804–810.
crossref
7.Vickers SP., Cheetham SC., Headland KR., Dickinson K., Grempler R., Mayoux E., Mark M., Klein T. Combination of the sodium-glucose cotransporter-2 inhibitor empagliflozin with orlistat or sibutramine further improves the body-weight reduction and glucose homeostasis of obese rats fed a cafeteria diet. Diabetes Metab Syndr Obes. 2014. 7:265–275.
crossref
8.Bae JS., Kim TH. Pancreatic lipase inhibitory and antioxidant activities of Zingiber officinale extracts. Korean J Food Preserv. 2011. 18(3):390–396.
crossref
9.Kumar P., Bhandari U., Jamadagni S. Fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats. Biomed Res Int. 2014. 2014:606021.
crossref
10.Wang H., Eckel RH. Lipoprotein lipase: from gene to obesity. Am J Physiol Endocrinol Metab. 2009. 297(2):E271–E288.
crossref
11.Braun JE., Severson DL. Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J. 1992. 287(Pt 2):337–347.
crossref
12.Fernández-Sánchez A., Madrigal-Santillán E., Bautista M., Esquivel-Soto J., Morales-González A., Esquivel-Chirino C., Durante-Montiel I., Sánchez-Rivera G., Valadez-Vega C., Morales-González JA. Inflammation, oxidative stress, and obesity. Int J Mol Sci. 2011. 12(5):3117–3132.
crossref
13.Moreno DA., Ilic N., Poulev A., Brasaemle DL., Fried SK., Raskin I. Inhibitory effects of grape seed extract on lipases. Nutrition. 2003. 19(10):876–879.
crossref
14.Baek J., Lee J., Kim K., Kim T., Kim D., Kim C., Tsutomu K., Ochir S., Lee K., Park CH., Lee YJ., Choe M. Inhibitory effects of Capsicum annuum L. water extracts on lipoprotein lipase activity in 3T3-L1 cells. Nutr Res Pract. 2013. 7(2):96–102.
15.Lee E. Antihyperlipidemic and antioxidant effects of Poncirus trifoliata. Korean J Plant Resour. 2006. 19(2):273–276.
16.Shim WS., Back H., Seo EK., Lee HT., Shim CK. Long-term administration of an aqueous extract of dried, immature fruit of Poncirus trifoliata (L.) Raf. suppresses body weight gain in rats. J Ethno-pharmacol. 2009. 126(2):294–299.
crossref
17.Oh SD., Kim M., Min BI., Choi GS., Kim SK., Bae H., Kang C., Kim DG., Park BJ., Kim CK. Effect of achyranthes bidentata blume on 3T3-L1 adipogenesis and rats fed with a high-fat diet. Evid Based Complement Alternat Med. 2014. 2014:158018.
18.Lee SM., Kang YH., Kim DJ., Kim KK., Lim JG., Kim TW., Choe M. Comparison of antioxidant and α-glucosidase inhibition activities among water extracts and sugar immersion extracts of green pepper, purslane and shiitake. J East Asian Soc Diet Life. 2014. 24(1):101–108.
crossref
19.Feng Z., Hai-ning Y., Xiao-man C., Zun-chen W., Sheng-rong S., Das UN. Effect of yellow capsicum extract on proliferation and differentiation of 3T3-L1 preadipocytes. Nutrition. 2014. 30(3):319–325.
crossref
20.Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev. 1998. 56(11):317–333.
crossref
21.Lee GW., Park SM., Yoo YC., Cho YH. Effect of ponciri fructus extracts fermented with ganoderma lucidum on the collagen synthesis and expression of matrix metalloproteinase-1. Korean J Biotechnol Bioeng. 2013. 28(2):106–114.
crossref
22.Klinger SC., Glerup S., Raarup MK., Mari MC., Nyegaard M., Koster G., Prabakaran T., Nilsson SK., Kjaergaard MM., Bakke O., Nykjær A., Olivecrona G., Petersen CM., Nielsen MS. SorLA regulates the activity of lipoprotein lipase by intracellular trafficking. J Cell Sci. 2011. 124(Pt 7):1095–1105.
crossref
23.Hirayama S., Bujo H., Yamazaki H., Kanaki T., Takahashi K., Kobayashi J., Schneider WJ., Saito Y. Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells. Biochem Biophys Res Commun. 2000. 275(2):365–373.
crossref
24.Kim EY., Baik IH., Kim JH., Kim SR., Rhyu MR. Screening of the antioxidant activity of some medicinal plants. Korean J Food Sci Technol. 2004. 36(2):333–338.
25.Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004. 79(5):727–747.
crossref
26.Kim EJ., Choi JY., Yu M., Kim MY., Lee S., Lee BH. Total polyphe-nols, total flavonoid contents, and antioxidant activity of Korean natural and medicinal plants. Korean J Food Sci Technol. 2012. 44(3):337–342.
crossref
27.Kumar S., Pandey AK. Chemistry and biological activities of flavonoids: an overview. ScientificWorldJournal. 2013. 2013:162750.
crossref
28.Goldberg IJ., Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Front Biosci. 2001. 6:D388–D405.
crossref
29.Wu LG., Hamid E., Shin W., Chiang HC. Exocytosis and endocytosis: modes, functions, and coupling mechanisms. Annu Rev Physiol. 2014. 76:301–331.
crossref
30.Söllner T., Whiteheart SW., Brunner M., Erdjument-Bromage H., Geromanos S., Tempst P., Rothman JE. SNAP receptors implicated in vesicle targeting and fusion. Nature. 1993. 362(6418):318–324.
crossref
31.Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol Rev. 2001. 81(1):153–208.
crossref
32.Hermey G. The Vps10p-domain receptor family. Cell Mol Life Sci. 2009. 66(16):2677–2689.
crossref
33.Nielsen MS., Jacobsen C., Olivecrona G., Gliemann J., Petersen CM. Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem. 1999. 274(13):8832–8836.
crossref

Fig. 1.
Effect of a water extract of the dried, immature fruit of Poncirus trifoliata (PF-W) on the viability of 3T3-L1 preadipocytes. 3T3-L1 cells were treated with PF-W (0.01, 0.025, 0.05, 0.1, 0.25, 0.5, or 1 mg/mL) for 24 h. Cell viability was determined using the Cell Counting Kit (CCK)-8. Data are expressed as Mean ± SD of triplicate experiments.
jnh-48-9f1.tif
Fig. 2.
Effect of a water extract of the dried, immature fruit of Poncirus trifoliata (PF-W) on the lipoprotein lipase (LPL) expression and activity in 3T3-L1 adipocytes. A: LPL content of 3T3-L1 cell culture medium. B: Comparison of LPL activities in cell extract with and without 0.25 mg/mL PF-W. C: LPL mRNA expression as a function of PF-W concentration and time of exposure. D: LPL content in 3T3-L1 cell extract. Data are expressed as Mean ± SD of triplicate experiments. #: p < 0.05, ##: p < 0.01 as compared to the preadipocytes. ∗: p < 0.05, ∗∗: p < 0.01 compared to control adipocytes.
jnh-48-9f2.tif
Fig. 3.
Effect of a water extract of the dried, immature fruit of Poncirus trifoliata (PF-W) on the mRNA expression levels of protein transport-related biomarkers in 3T3-L1 adipocytes. 3T3-L1 cells were treated with PF-W (0.25 mg/mL) for 6 and 12 h. A: v-SNARE mRNA expression. B: Rab3A mRNA expression. C: Sortilin (SorLA) mRNA expression. D: SorLA mRNA expression. Data are expressed as Mean ± SD of triplicate experiments. #: p < 0.05, ##: p < 0.01 compared to the preadipocyte. ∗: p < 0.05 compared to the adipocyte.
jnh-48-9f3.tif
Fig. 4.
Effect of a water extract of the dried, immature fruit of Poncirus trifoliata (PF-W) on C/EBPβ expression in 3T3-L1 adipocytes. 3T3-L1 cells were treated with PF-W (0.25 mg/mL) for 12 h. A: C/ EBPβ mRNA expression by PF-W treatment. B: C/EBPβ protein expression in cytoplasmic and nuclear protein fraction by PF-W treatment. Data are expressed as Mean ± SD of triplicate experiments. ∗: p < 0.05 and ∗∗: p < 0.01.
jnh-48-9f4.tif
Table 1.
PCR primer sets and expected sizes of PCR products use in the experiment
Gene   Primer (5'-3') Size (bp)
LPL forward ATC CAT GGA TGG ACG GTA AC 483
reverse CTG GAT CCC AAT ACT TCG AC
v-SNARE forward AAT TCC ACC CCA AAG TCG AG 224
reverse ACC CAG CCT CTA GTC TCC GA
Rab3A forward CTA CCG CAA CGA CAA GAG GA 221
reverse CAC ACT TGT TTC CCA CCA GC
Sortilin forward ACA AAG ACG GCT GCA TTT TG 282
reverse GGC ATT TGT CTC CTG GGA TT
SorLA forward CAG CAG TCC ACC AGC TCC TA 194
reverse ACT GCT CAT CCT TGC TGA CG
C/EBPβ forward CTG AGC GAC GAG TAC AAG AT 445
reverse TTG ATC CGG ATT GCA TCA AG
GAPDH forward GGA GCC AAA AGG GTC ATC AT 203
reverse GTG ATG GCA TGG ACT GTG GT
Table 2.
PCR condition of each primer sets
Gene Pre-denaturation Denaturation Annealing Extension Final extension
LPL 95oC 5 min 95oC, 30 sec 56oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
v-SNARE 95oC 5 min 95oC, 30 sec 55.4oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
Rab3A 95oC 5 min 95oC, 30 sec 57.5oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
Sortilin 95oC 5 min 95oC, 30 sec 55oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
SorLA 95oC 5 min 95oC, 30 sec 59oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
C/EBPβ 95oC 5 min 95oC, 30 sec 59oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
GAPDH 95oC 5 min 95oC, 30 sec 55oC, 30 sec 72oC, 30 sec 72oC 5 min
30 cycle
Table 3.
The contents of total polyphenol and flavonoid of Poncirus trifoliata water extract (PF-W)
Sample Total polyphenol (mg/g, GAE1)) Total flavonoid (mg/g, QE2))
PF-W 52.15 ± 4.02 6.56 ± 0.47

Values are presented as Mean ± SD from three independent experiments.

1) GAE, gallic acid equivalents

2) QE, quercetin equivalents

Table 4.
The half maximal inhibitory concentration (IC50) of Ponci rus trifoliata water extract (PFW)
Anti-oxidant experiments IC50 (mg/mL)
Ascorbic acid PF-W
DPPH radical scavenging activity 0.027 1.931
ABTS radical scavenging activity 0.092 1.536
Reducing power 0.069 2.098
SOD-like activity 0.129 11.53
TOOLS
Similar articles